Today: Today, 21,760 Shares of Mindbody Inc. (MB) Stock are sold by Richard Lee Stollmeyer

Today, 21,760 Shares of Mindbody Inc. (MB) Stock are sold by Richard Lee Stollmeyer

Mindbody Inc. (NASDAQ:MB) CEO Richard Lee Stollmeyer sold 21,760 shares of the business’s stock in a transaction on Monday, October 3rd. The stock was sold at an average price of $19.44, for a total transaction of $423,014.40. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Richard Lee Stollmeyer also recently made the following trade(s): On Thursday, September 1st, Richard Lee Stollmeyer sold 21,760 shares of Mindbody stock. The shares were sold at an average price of $17.35, for a total transaction of $377,536.00. On Monday, August 1st, Richard Lee Stollmeyer sold 21,760 shares of Mindbody stock. The shares were sold at an average price of $17.40, for a total transaction of $378,624.00.

Shares of Mindbody Inc. (NASDAQ:MB) opened at 19.93 on Friday. The company’s market cap is $791.72 million. Mindbody Inc. has a 12-month low of $9.20 and a 12-month high of $20.83. The stock has a 50 day moving average of $17.94 and a 200 day moving average of $15.74.

Mindbody (NASDAQ:MB) last announced its quarterly earnings results on Wednesday, July 27th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.04. Mindbody had a negative return on equity of 30.95% and a negative net margin of 27.12%. The business earned $33.60 million during the quarter, compared to the consensus estimate of $33.22 million. During the same quarter last year, the firm posted ($0.21) EPS. The company’s quarterly revenue was up 35.5% on a year-over-year basis. On average, equities analysts expect that Mindbody Inc. will post ($0.44) earnings per share for the current fiscal year.

A number of large investors have recently made changes to their positions in MB. JPMorgan Chase & Co. increased its stake in shares of Mindbody by 595,629.9% in the first quarter. JPMorgan Chase & Co. now owns 637,431 shares of the company’s stock valued at $8,497,000 after buying an additional 637,324 shares in the last quarter. Royce & Associates LP increased its stake in shares of Mindbody by 159.2% in the first quarter. Royce & Associates LP now owns 68,551 shares of the company’s stock valued at $914,000 after buying an additional 42,100 shares in the last quarter. State Street Corp increased its stake in shares of Mindbody by 20.1% in the first quarter. State Street Corp now owns 96,558 shares of the company’s stock valued at $1,289,000 after buying an additional 16,172 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Mindbody by 57.2% in the first quarter. Geode Capital Management LLC now owns 67,153 shares of the company’s stock valued at $895,000 after buying an additional 24,444 shares in the last quarter. Finally, Granahan Investment Management Inc. MA increased its stake in shares of Mindbody by 11.4% in the first quarter. Granahan Investment Management Inc. MA now owns 626,958 shares of the company’s stock valued at $8,357,000 after buying an additional 64,238 shares in the last quarter. 38.49% of the stock is owned by institutional investors and hedge funds.

Several equities research analysts have issued reports on the stock. Zacks Investment Research raised shares of Mindbody from a “hold” rating to a “buy” rating and set a $21.00 price target on the stock in a report on Wednesday, September 28th. Roth Capital assumed coverage on shares of Mindbody in a report on Friday, September 23rd. They issued a “buy” rating and a $22.50 price target on the stock. JMP Securities boosted their price target on shares of Mindbody from $19.00 to $25.00 and gave the company a “market outperform” rating in a report on Thursday, July 28th. Pacific Crest boosted their price target on shares of Mindbody from $19.00 to $20.00 and gave the company an “overweight” rating in a report on Thursday, July 28th. Finally, Morgan Stanley boosted their price target on shares of Mindbody from $17.00 to $20.00 and gave the company an “equal weight” rating in a report on Thursday, July 28th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $22.07.

About Mindbody

Related posts

Leave a Comment